Alzheimer'
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. the moderate to severe Alzheimer's disease patients 2. outpatient 3. treatment of acethylcholinesterase inhibitor for more than 6 months and unchanged dosage for 3 months recently
Exclusion criteria
Exclusion criteria: 1. dementia patients except Alzheimer's disease 2. the patients who have severe mental disorders 3. the patients having the serious disease including the malignant neoplasm 4. the patients with a history of the hypersensitivity for memantine hydrochloride 5. In addition, the case that a principal investigator or subinvestigator judged to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BPSD Evaluations are performed at baseline (month 0), and at month 3, 6 and 12. | — |
Secondary
| Measure | Time frame |
|---|---|
| cognitive function, caregiver's burden Evaluations are performed at baseline (month 0), and at month 3, 6 and 12. | — |
Countries
Japan
Contacts
Faculty of Medicine, University of Miyazaki Division of Psychiatry, Department of Clinical Neuroscience,